Violation Tracker Parent Company Summary

Parent Company Name: 
Boehringer Ingelheim
Ownership Structure: 
privately held
Headquartered in: 
Germany
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$137,622,000
Number of records: 
12
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$108,500,0003
government-contracting-related offenses$29,057,0007
employment-related offenses$50,0001
safety-related offenses$15,0001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$108,500,0003
False Claims Act and related$29,057,0007
labor relations violation$50,0001
aviation safety violation$15,0001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

Boehringer Ingelheim Corp.; BOEHRINGER INGELHEIM PHARMACEUTICAL; Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc.; Boehringer Ingelheim Roxane, Inc. et al.; Boehringer Ingleheim

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Boehringer Ingelheim Pharmaceuticals Inc. off-label or unapproved promotion of medical products 2012 FDA $95,000,000
Boehringer-Ingelheim Pharmaceuticals, Inc. off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $95,000,000
Boehringer Ingelheim Pharmaceuticals, Inc. off-label or unapproved promotion of medical products 2017 MULTI-AG $13,500,000
Boehringer Ingelheim Corp. False Claims Act and related 2005 TX-AG $10,000,000
Boehringer Ingelheim Pharmaceuticals, Inc. False Claims Act and related 2010 WI-AG $7,750,000
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. False Claims Act and related 2009 KY-AG $4,500,000
Boehringer Ingelheim False Claims Act and related 2012 LA-AG $3,250,000
Boehringer Ingelheim Roxane, Inc. False Claims Act and related 2008 MA-AG $1,800,000
Boehringer Ingleheim False Claims Act and related 2011 KS-AG $1,400,000
Boehringer Ingelheim Roxane, Inc. et al. False Claims Act and related 2009 IA-AG $357,000
Boehringer Ingelheim Pharmaceutical, Inc. labor relations violation 2004 NLRB $50,000
BOEHRINGER INGELHEIM PHARMACEUTICALS aviation safety violation 2014 FAA $15,000
Download results as CSV or XML